Loading…
Functional and clinical characterization of KCNJ2 mutations associated with LQT7 (Andersen syndrome)
Andersen syndrome (AS) is a rare, inherited disorder characterized by periodic paralysis, long QT (LQT) with ventricular arrhythmias, and skeletal developmental abnormalities. We recently established that AS is caused by mutations in KCNJ2, which encodes the inward rectifier K(+) channel Kir2.1. In...
Saved in:
Published in: | The Journal of clinical investigation 2002-08, Vol.110 (3), p.381-388 |
---|---|
Main Authors: | , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c3093-52fa6fcee13e5130ccf287cb675621fac68551882931da8c661caf6a2fd2451b3 |
---|---|
cites | cdi_FETCH-LOGICAL-c3093-52fa6fcee13e5130ccf287cb675621fac68551882931da8c661caf6a2fd2451b3 |
container_end_page | 388 |
container_issue | 3 |
container_start_page | 381 |
container_title | The Journal of clinical investigation |
container_volume | 110 |
creator | Tristani-Firouzi, Martin Jensen, Judy L Donaldson, Matthew R Sansone, Valeria Meola, Giovanni Hahn, Angelika Bendahhou, Said Kwiecinski, Hubert Fidzianska, Anna Plaster, Nikki Fu, Ying-Hui Ptacek, Louis J Tawil, Rabi |
description | Andersen syndrome (AS) is a rare, inherited disorder characterized by periodic paralysis, long QT (LQT) with ventricular arrhythmias, and skeletal developmental abnormalities. We recently established that AS is caused by mutations in KCNJ2, which encodes the inward rectifier K(+) channel Kir2.1. In this report, we characterized the functional consequences of three novel and seven previously described KCNJ2 mutations using a two-microelectrode voltage-clamp technique and correlated the findings with the clinical phenotype. All mutations resulted in loss of function and dominant-negative suppression of Kir2.1 channel function. In mutation carriers, the frequency of periodic paralysis was 64% and dysmorphic features 78%. LQT was the primary cardiac manifestation, present in 71% of KCNJ2 mutation carriers, with ventricular arrhythmias present in 64%. While arrhythmias were common, none of our subjects suffered sudden cardiac death. To gain insight into the mechanism of arrhythmia susceptibility, we simulated the effect of reduced Kir2.1 using a ventricular myocyte model. A reduction in Kir2.1 prolonged the terminal phase of the cardiac action potential, and in the setting of reduced extracellular K(+), induced Na(+)/Ca(2+) exchanger-dependent delayed afterdepolarizations and spontaneous arrhythmias. These findings suggest that the substrate for arrhythmia susceptibility in AS is distinct from the other forms of inherited LQT syndrome. |
doi_str_mv | 10.1172/JCI15183 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_151085</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>71986232</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3093-52fa6fcee13e5130ccf287cb675621fac68551882931da8c661caf6a2fd2451b3</originalsourceid><addsrcrecordid>eNpdkU1vFDEMhiMEosuCxC9AEQfUHqbEySSTOXCoVvRzBUIq5yjrSdhUM0lJZkDl13fabvk6WbYfW6_9EvIa2CFAw9-fr85AghZPyAKk1JXmQj8lC8Y4VG0j9B55UcoVY1DXsn5O9oCDErVsFqQ7niKOIUXbUxs7in2IAecEtzZbHF0Ov-xdnyZPL1afzjkdpvG-UqgtJWGwo-vozzBu6frLZUP3j2LncnGRlpvY5TS4g5fkmbd9ca92cUm-Hn-8XJ1W688nZ6ujdYWCtaKS3Fvl0TkQToJgiJ7rBjeqkYqDt6i0nK_UvBXQWY1KAVqvLPcdryVsxJJ8eNh7PW0G16GLY7a9uc5hsPnGJBvMv50YtuZb-mHm5zEt5_l3u_mcvk-ujGYIBV3f2-jSVEwDrVZc8Bl8-x94laY8_7AYzpjk0M76l2T_AcKcSsnO_xYCzNzZZh5tm9E3fwv_A-58ErdS1JLI</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>200521951</pqid></control><display><type>article</type><title>Functional and clinical characterization of KCNJ2 mutations associated with LQT7 (Andersen syndrome)</title><source>Open Access: PubMed Central</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Tristani-Firouzi, Martin ; Jensen, Judy L ; Donaldson, Matthew R ; Sansone, Valeria ; Meola, Giovanni ; Hahn, Angelika ; Bendahhou, Said ; Kwiecinski, Hubert ; Fidzianska, Anna ; Plaster, Nikki ; Fu, Ying-Hui ; Ptacek, Louis J ; Tawil, Rabi</creator><creatorcontrib>Tristani-Firouzi, Martin ; Jensen, Judy L ; Donaldson, Matthew R ; Sansone, Valeria ; Meola, Giovanni ; Hahn, Angelika ; Bendahhou, Said ; Kwiecinski, Hubert ; Fidzianska, Anna ; Plaster, Nikki ; Fu, Ying-Hui ; Ptacek, Louis J ; Tawil, Rabi</creatorcontrib><description>Andersen syndrome (AS) is a rare, inherited disorder characterized by periodic paralysis, long QT (LQT) with ventricular arrhythmias, and skeletal developmental abnormalities. We recently established that AS is caused by mutations in KCNJ2, which encodes the inward rectifier K(+) channel Kir2.1. In this report, we characterized the functional consequences of three novel and seven previously described KCNJ2 mutations using a two-microelectrode voltage-clamp technique and correlated the findings with the clinical phenotype. All mutations resulted in loss of function and dominant-negative suppression of Kir2.1 channel function. In mutation carriers, the frequency of periodic paralysis was 64% and dysmorphic features 78%. LQT was the primary cardiac manifestation, present in 71% of KCNJ2 mutation carriers, with ventricular arrhythmias present in 64%. While arrhythmias were common, none of our subjects suffered sudden cardiac death. To gain insight into the mechanism of arrhythmia susceptibility, we simulated the effect of reduced Kir2.1 using a ventricular myocyte model. A reduction in Kir2.1 prolonged the terminal phase of the cardiac action potential, and in the setting of reduced extracellular K(+), induced Na(+)/Ca(2+) exchanger-dependent delayed afterdepolarizations and spontaneous arrhythmias. These findings suggest that the substrate for arrhythmia susceptibility in AS is distinct from the other forms of inherited LQT syndrome.</description><identifier>ISSN: 0021-9738</identifier><identifier>EISSN: 1558-8238</identifier><identifier>DOI: 10.1172/JCI15183</identifier><identifier>PMID: 12163457</identifier><language>eng</language><publisher>United States: American Society for Clinical Investigation</publisher><subject>Adolescent ; Adult ; Animals ; Arrhythmias, Cardiac ; Biomedical research ; Cardiac arrhythmia ; Child ; Electrophysiology ; Female ; Genotype & phenotype ; Heart - physiopathology ; Heart Defects, Congenital ; Humans ; Long QT Syndrome - genetics ; Long QT Syndrome - physiopathology ; Male ; Middle Aged ; Mutation ; Paralyses, Familial Periodic - genetics ; Paralyses, Familial Periodic - physiopathology ; Potassium Channels, Inwardly Rectifying - genetics ; Potassium Channels, Inwardly Rectifying - physiology ; Rabbits ; Syndrome</subject><ispartof>The Journal of clinical investigation, 2002-08, Vol.110 (3), p.381-388</ispartof><rights>Copyright American Society for Clinical Investigation Aug 2002</rights><rights>Copyright © 2002, American Society for Clinical Investigation 2002</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3093-52fa6fcee13e5130ccf287cb675621fac68551882931da8c661caf6a2fd2451b3</citedby><cites>FETCH-LOGICAL-c3093-52fa6fcee13e5130ccf287cb675621fac68551882931da8c661caf6a2fd2451b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC151085/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC151085/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12163457$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tristani-Firouzi, Martin</creatorcontrib><creatorcontrib>Jensen, Judy L</creatorcontrib><creatorcontrib>Donaldson, Matthew R</creatorcontrib><creatorcontrib>Sansone, Valeria</creatorcontrib><creatorcontrib>Meola, Giovanni</creatorcontrib><creatorcontrib>Hahn, Angelika</creatorcontrib><creatorcontrib>Bendahhou, Said</creatorcontrib><creatorcontrib>Kwiecinski, Hubert</creatorcontrib><creatorcontrib>Fidzianska, Anna</creatorcontrib><creatorcontrib>Plaster, Nikki</creatorcontrib><creatorcontrib>Fu, Ying-Hui</creatorcontrib><creatorcontrib>Ptacek, Louis J</creatorcontrib><creatorcontrib>Tawil, Rabi</creatorcontrib><title>Functional and clinical characterization of KCNJ2 mutations associated with LQT7 (Andersen syndrome)</title><title>The Journal of clinical investigation</title><addtitle>J Clin Invest</addtitle><description>Andersen syndrome (AS) is a rare, inherited disorder characterized by periodic paralysis, long QT (LQT) with ventricular arrhythmias, and skeletal developmental abnormalities. We recently established that AS is caused by mutations in KCNJ2, which encodes the inward rectifier K(+) channel Kir2.1. In this report, we characterized the functional consequences of three novel and seven previously described KCNJ2 mutations using a two-microelectrode voltage-clamp technique and correlated the findings with the clinical phenotype. All mutations resulted in loss of function and dominant-negative suppression of Kir2.1 channel function. In mutation carriers, the frequency of periodic paralysis was 64% and dysmorphic features 78%. LQT was the primary cardiac manifestation, present in 71% of KCNJ2 mutation carriers, with ventricular arrhythmias present in 64%. While arrhythmias were common, none of our subjects suffered sudden cardiac death. To gain insight into the mechanism of arrhythmia susceptibility, we simulated the effect of reduced Kir2.1 using a ventricular myocyte model. A reduction in Kir2.1 prolonged the terminal phase of the cardiac action potential, and in the setting of reduced extracellular K(+), induced Na(+)/Ca(2+) exchanger-dependent delayed afterdepolarizations and spontaneous arrhythmias. These findings suggest that the substrate for arrhythmia susceptibility in AS is distinct from the other forms of inherited LQT syndrome.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Animals</subject><subject>Arrhythmias, Cardiac</subject><subject>Biomedical research</subject><subject>Cardiac arrhythmia</subject><subject>Child</subject><subject>Electrophysiology</subject><subject>Female</subject><subject>Genotype & phenotype</subject><subject>Heart - physiopathology</subject><subject>Heart Defects, Congenital</subject><subject>Humans</subject><subject>Long QT Syndrome - genetics</subject><subject>Long QT Syndrome - physiopathology</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Mutation</subject><subject>Paralyses, Familial Periodic - genetics</subject><subject>Paralyses, Familial Periodic - physiopathology</subject><subject>Potassium Channels, Inwardly Rectifying - genetics</subject><subject>Potassium Channels, Inwardly Rectifying - physiology</subject><subject>Rabbits</subject><subject>Syndrome</subject><issn>0021-9738</issn><issn>1558-8238</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><recordid>eNpdkU1vFDEMhiMEosuCxC9AEQfUHqbEySSTOXCoVvRzBUIq5yjrSdhUM0lJZkDl13fabvk6WbYfW6_9EvIa2CFAw9-fr85AghZPyAKk1JXmQj8lC8Y4VG0j9B55UcoVY1DXsn5O9oCDErVsFqQ7niKOIUXbUxs7in2IAecEtzZbHF0Ov-xdnyZPL1afzjkdpvG-UqgtJWGwo-vozzBu6frLZUP3j2LncnGRlpvY5TS4g5fkmbd9ca92cUm-Hn-8XJ1W688nZ6ujdYWCtaKS3Fvl0TkQToJgiJ7rBjeqkYqDt6i0nK_UvBXQWY1KAVqvLPcdryVsxJJ8eNh7PW0G16GLY7a9uc5hsPnGJBvMv50YtuZb-mHm5zEt5_l3u_mcvk-ujGYIBV3f2-jSVEwDrVZc8Bl8-x94laY8_7AYzpjk0M76l2T_AcKcSsnO_xYCzNzZZh5tm9E3fwv_A-58ErdS1JLI</recordid><startdate>20020801</startdate><enddate>20020801</enddate><creator>Tristani-Firouzi, Martin</creator><creator>Jensen, Judy L</creator><creator>Donaldson, Matthew R</creator><creator>Sansone, Valeria</creator><creator>Meola, Giovanni</creator><creator>Hahn, Angelika</creator><creator>Bendahhou, Said</creator><creator>Kwiecinski, Hubert</creator><creator>Fidzianska, Anna</creator><creator>Plaster, Nikki</creator><creator>Fu, Ying-Hui</creator><creator>Ptacek, Louis J</creator><creator>Tawil, Rabi</creator><general>American Society for Clinical Investigation</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BEC</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>NAPCQ</scope><scope>PHGZM</scope><scope>PHGZT</scope><scope>PJZUB</scope><scope>PKEHL</scope><scope>PPXIY</scope><scope>PQEST</scope><scope>PQGLB</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>S0X</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20020801</creationdate><title>Functional and clinical characterization of KCNJ2 mutations associated with LQT7 (Andersen syndrome)</title><author>Tristani-Firouzi, Martin ; Jensen, Judy L ; Donaldson, Matthew R ; Sansone, Valeria ; Meola, Giovanni ; Hahn, Angelika ; Bendahhou, Said ; Kwiecinski, Hubert ; Fidzianska, Anna ; Plaster, Nikki ; Fu, Ying-Hui ; Ptacek, Louis J ; Tawil, Rabi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3093-52fa6fcee13e5130ccf287cb675621fac68551882931da8c661caf6a2fd2451b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Animals</topic><topic>Arrhythmias, Cardiac</topic><topic>Biomedical research</topic><topic>Cardiac arrhythmia</topic><topic>Child</topic><topic>Electrophysiology</topic><topic>Female</topic><topic>Genotype & phenotype</topic><topic>Heart - physiopathology</topic><topic>Heart Defects, Congenital</topic><topic>Humans</topic><topic>Long QT Syndrome - genetics</topic><topic>Long QT Syndrome - physiopathology</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Mutation</topic><topic>Paralyses, Familial Periodic - genetics</topic><topic>Paralyses, Familial Periodic - physiopathology</topic><topic>Potassium Channels, Inwardly Rectifying - genetics</topic><topic>Potassium Channels, Inwardly Rectifying - physiology</topic><topic>Rabbits</topic><topic>Syndrome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tristani-Firouzi, Martin</creatorcontrib><creatorcontrib>Jensen, Judy L</creatorcontrib><creatorcontrib>Donaldson, Matthew R</creatorcontrib><creatorcontrib>Sansone, Valeria</creatorcontrib><creatorcontrib>Meola, Giovanni</creatorcontrib><creatorcontrib>Hahn, Angelika</creatorcontrib><creatorcontrib>Bendahhou, Said</creatorcontrib><creatorcontrib>Kwiecinski, Hubert</creatorcontrib><creatorcontrib>Fidzianska, Anna</creatorcontrib><creatorcontrib>Plaster, Nikki</creatorcontrib><creatorcontrib>Fu, Ying-Hui</creatorcontrib><creatorcontrib>Ptacek, Louis J</creatorcontrib><creatorcontrib>Tawil, Rabi</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest Hospital Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>eLibrary</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>ProQuest Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Biological Sciences</collection><collection>Health & Medical Collection (Alumni)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest Central (New)</collection><collection>ProQuest One Academic (New)</collection><collection>ProQuest Health & Medical Research Collection</collection><collection>ProQuest One Academic Middle East (New)</collection><collection>ProQuest One Health & Nursing</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Applied & Life Sciences</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>SIRS Editorial</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The Journal of clinical investigation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tristani-Firouzi, Martin</au><au>Jensen, Judy L</au><au>Donaldson, Matthew R</au><au>Sansone, Valeria</au><au>Meola, Giovanni</au><au>Hahn, Angelika</au><au>Bendahhou, Said</au><au>Kwiecinski, Hubert</au><au>Fidzianska, Anna</au><au>Plaster, Nikki</au><au>Fu, Ying-Hui</au><au>Ptacek, Louis J</au><au>Tawil, Rabi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Functional and clinical characterization of KCNJ2 mutations associated with LQT7 (Andersen syndrome)</atitle><jtitle>The Journal of clinical investigation</jtitle><addtitle>J Clin Invest</addtitle><date>2002-08-01</date><risdate>2002</risdate><volume>110</volume><issue>3</issue><spage>381</spage><epage>388</epage><pages>381-388</pages><issn>0021-9738</issn><eissn>1558-8238</eissn><abstract>Andersen syndrome (AS) is a rare, inherited disorder characterized by periodic paralysis, long QT (LQT) with ventricular arrhythmias, and skeletal developmental abnormalities. We recently established that AS is caused by mutations in KCNJ2, which encodes the inward rectifier K(+) channel Kir2.1. In this report, we characterized the functional consequences of three novel and seven previously described KCNJ2 mutations using a two-microelectrode voltage-clamp technique and correlated the findings with the clinical phenotype. All mutations resulted in loss of function and dominant-negative suppression of Kir2.1 channel function. In mutation carriers, the frequency of periodic paralysis was 64% and dysmorphic features 78%. LQT was the primary cardiac manifestation, present in 71% of KCNJ2 mutation carriers, with ventricular arrhythmias present in 64%. While arrhythmias were common, none of our subjects suffered sudden cardiac death. To gain insight into the mechanism of arrhythmia susceptibility, we simulated the effect of reduced Kir2.1 using a ventricular myocyte model. A reduction in Kir2.1 prolonged the terminal phase of the cardiac action potential, and in the setting of reduced extracellular K(+), induced Na(+)/Ca(2+) exchanger-dependent delayed afterdepolarizations and spontaneous arrhythmias. These findings suggest that the substrate for arrhythmia susceptibility in AS is distinct from the other forms of inherited LQT syndrome.</abstract><cop>United States</cop><pub>American Society for Clinical Investigation</pub><pmid>12163457</pmid><doi>10.1172/JCI15183</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0021-9738 |
ispartof | The Journal of clinical investigation, 2002-08, Vol.110 (3), p.381-388 |
issn | 0021-9738 1558-8238 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_151085 |
source | Open Access: PubMed Central; EZB-FREE-00999 freely available EZB journals |
subjects | Adolescent Adult Animals Arrhythmias, Cardiac Biomedical research Cardiac arrhythmia Child Electrophysiology Female Genotype & phenotype Heart - physiopathology Heart Defects, Congenital Humans Long QT Syndrome - genetics Long QT Syndrome - physiopathology Male Middle Aged Mutation Paralyses, Familial Periodic - genetics Paralyses, Familial Periodic - physiopathology Potassium Channels, Inwardly Rectifying - genetics Potassium Channels, Inwardly Rectifying - physiology Rabbits Syndrome |
title | Functional and clinical characterization of KCNJ2 mutations associated with LQT7 (Andersen syndrome) |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-03-07T02%3A59%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Functional%20and%20clinical%20characterization%20of%20KCNJ2%20mutations%20associated%20with%20LQT7%20(Andersen%20syndrome)&rft.jtitle=The%20Journal%20of%20clinical%20investigation&rft.au=Tristani-Firouzi,%20Martin&rft.date=2002-08-01&rft.volume=110&rft.issue=3&rft.spage=381&rft.epage=388&rft.pages=381-388&rft.issn=0021-9738&rft.eissn=1558-8238&rft_id=info:doi/10.1172/JCI15183&rft_dat=%3Cproquest_pubme%3E71986232%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3093-52fa6fcee13e5130ccf287cb675621fac68551882931da8c661caf6a2fd2451b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=200521951&rft_id=info:pmid/12163457&rfr_iscdi=true |